A fully automated system for performing individual donation (ID) - Nucleic Acid Amplification Technology (NAT) testing of IBTS donations in human plasma. The NAT laboratory currently tests approximately 150 000 donations/samples annually. HIV RNA, HCV RNA and HBV DNA NAT testing of IBTS donations and samples in individual donation format. In addition, the system must perform ID-NAT testing for Hepatitis E virus (HEV) and West Nile Virus (WNV) RNA, and future capability for NAT testing of additional viral markers on the proposed system testing platform e.g. Zika virus testing. The ID-NAT Testing system will include testing reagents, consumables, equipment, operating software, servicing and maintenance.
Deadline
The time limit for receipt of tenders was 2017-05-12.
The procurement was published on 2017-04-10.
Suppliers
The following suppliers are mentioned in award decisions or other procurement documents:
Contract notice (2017-04-10) Object Scope of the procurement
Title: Blood-testing reagents
Reference number: IBTS/010/2017
Short description:
A fully automated system for performing individual donation (ID) - Nucleic Acid Amplification Technology (NAT) testing of IBTS donations in human plasma. The NAT laboratory currently tests approximately 150 000 donations/samples annually. HIV RNA, HCV RNA and HBV DNA NAT testing of IBTS donations and samples in individual donation format. In addition, the system must perform ID-NAT testing for Hepatitis E virus (HEV) and West Nile Virus (WNV) RNA, and future capability for NAT testing of additional viral markers on the proposed system testing platform e.g. Zika virus testing.
The ID-NAT Testing system will include testing reagents, consumables, equipment, operating software, servicing and maintenance.
A fully automated system for performing individual donation (ID) - Nucleic Acid Amplification Technology (NAT) testing of IBTS donations in human plasma. The NAT laboratory currently tests approximately 150 000 donations/samples annually. HIV RNA, HCV RNA and HBV DNA NAT testing of IBTS donations and samples in individual donation format. In addition, the system must perform ID-NAT testing for Hepatitis E virus (HEV) and West Nile Virus (WNV) RNA, and future capability for NAT testing of additional viral markers on the proposed system testing platform e.g. Zika virus testing.
The ID-NAT Testing system will include testing reagents, consumables, equipment, operating software, servicing and maintenance.
Notice metadata
Original language: English ๐ฃ๏ธ
Document type: Contract notice
Nature of contract: Supplies
Regulation: European Union, with participation of GPA countries
Common procurement vocabulary (CPV)
Code: Blood-testing reagents๐ฆ
Additional CPV: Laboratory reagents๐ฆ Place of performance
NUTS region: รire/Ireland
๐๏ธ
Procedure
Procedure type: Open procedure
Type of bid: Submission for all lots
Award criteria
The most economic tender
The effective contract start date will be from successful validation of equipment and consumables.
Object Scope of the procurement
Short description:
A fully automated system for performing individual donation (ID) - Nucleic Acid Amplification Technology (NAT) testing of IBTS donations in human plasma. The NAT laboratory currently tests approximately 150 000 donations/samples annually. HIV RNA, HCV RNA and HBV DNA NAT testing of IBTS donations and samples in individual donation format. In addition, the system must perform ID-NAT testing for Hepatitis E virus (HEV) and West Nile Virus (WNV) RNA, and future capability for NAT testing of additional viral markers on the proposed system testing platform e.g. Zika virus testing.
A fully automated system for performing individual donation (ID) - Nucleic Acid Amplification Technology (NAT) testing of IBTS donations in human plasma. The NAT laboratory currently tests approximately 150 000 donations/samples annually. HIV RNA, HCV RNA and HBV DNA NAT testing of IBTS donations and samples in individual donation format. In addition, the system must perform ID-NAT testing for Hepatitis E virus (HEV) and West Nile Virus (WNV) RNA, and future capability for NAT testing of additional viral markers on the proposed system testing platform e.g. Zika virus testing.
The ID-NAT Testing system will include testing reagents, consumables, equipment, operating software, servicing and maintenance.
Estimated total value: 7 400 000 EUR ๐ฐ
Short description:
A fully automated system for performing individual donation (ID)- Nucleic Acid Amplification Technology (NAT) testing of IBTS donations in human plasma. The NAT laboratory currently tests approximately 150 000 donations/samples annually. HIV RNA, HCV RNA and HBV DNA NAT testing of IBTS donations and samples in individual donation format. In addition, the system must perform ID-NAT testing for Hepatitis E virus (HEV) and West Nile Virus (WNV) RNA, and future capability for NAT testing of additional viral markers on the proposed system testing platform e.g. Zika virus testing.
A fully automated system for performing individual donation (ID)- Nucleic Acid Amplification Technology (NAT) testing of IBTS donations in human plasma. The NAT laboratory currently tests approximately 150 000 donations/samples annually. HIV RNA, HCV RNA and HBV DNA NAT testing of IBTS donations and samples in individual donation format. In addition, the system must perform ID-NAT testing for Hepatitis E virus (HEV) and West Nile Virus (WNV) RNA, and future capability for NAT testing of additional viral markers on the proposed system testing platform e.g. Zika virus testing.
Estimated value excluding VAT: 7 400 000 EUR ๐ฐ
Duration: 48 months
Description of renewals: The IBTS reserves the right to extend the contract for 12 months.
Additional information:
The effective contract start date will be from successful validation of equipment and consumables.
Legal, economic, financial and technical information Conditions for participation
Suitability to pursue the professional activity: As per RFT.
Economic and financial standing: As per RFT.
Technical and professional ability: As per RFT.
Minimum level(s) of standards: As per RFT.
Procedure
Time of receipt of tenders: 12:00
Languages in which tenders or requests to participate may be submitted: English ๐ฃ๏ธ
Tender validity period: 2017-08-25 ๐
Tender opening date: 2017-05-12 ๐
Tender opening time: 12:00
Place: Electronic postbox.
Complementary information Review body
Name: Remedies Directive applies
Postal town: Dublin
Country: Ireland ๐ฎ๐ช Body responsible for mediation procedures Same as: Review body
Source: OJS 2017/S 072-136779 (2017-04-10)
Contract award notice (2017-11-16) Object Scope of the procurement
Short description:
A fully automated system for performing individual donation (ID)- Nucleic Acid Amplification Technology (NAT) testing of IBTS donations in human plasma. The NAT laboratory currently tests approximately 150,000 donations/samples annually. HIV RNA, HCV RNA and HBV DNA NAT testing of IBTS donations and samples in individual donation format. In addition, the system must perform ID-NAT testing for Hepatitis E virus (HEV) and West Nile Virus (WNV) RNA, and future capability for NAT testing of additional viral markers on the proposed system testing platform e.g. Zika virus testing.
The ID-NAT Testing system will include testing reagents, consumables, equipment, operating software, servicing and maintenance.
A fully automated system for performing individual donation (ID)- Nucleic Acid Amplification Technology (NAT) testing of IBTS donations in human plasma. The NAT laboratory currently tests approximately 150,000 donations/samples annually. HIV RNA, HCV RNA and HBV DNA NAT testing of IBTS donations and samples in individual donation format. In addition, the system must perform ID-NAT testing for Hepatitis E virus (HEV) and West Nile Virus (WNV) RNA, and future capability for NAT testing of additional viral markers on the proposed system testing platform e.g. Zika virus testing.
The ID-NAT Testing system will include testing reagents, consumables, equipment, operating software, servicing and maintenance.
Total value of the procurement: 7 485 000 EUR ๐ฐ
Notice metadata
Document type: Contract award notice
Object Scope of the procurement
Short description:
A fully automated system for performing individual donation (ID)- Nucleic Acid Amplification Technology (NAT) testing of IBTS donations in human plasma. The NAT laboratory currently tests approximately 150,000 donations/samples annually. HIV RNA, HCV RNA and HBV DNA NAT testing of IBTS donations and samples in individual donation format. In addition, the system must perform ID-NAT testing for Hepatitis E virus (HEV) and West Nile Virus (WNV) RNA, and future capability for NAT testing of additional viral markers on the proposed system testing platform e.g. Zika virus testing.
A fully automated system for performing individual donation (ID)- Nucleic Acid Amplification Technology (NAT) testing of IBTS donations in human plasma. The NAT laboratory currently tests approximately 150,000 donations/samples annually. HIV RNA, HCV RNA and HBV DNA NAT testing of IBTS donations and samples in individual donation format. In addition, the system must perform ID-NAT testing for Hepatitis E virus (HEV) and West Nile Virus (WNV) RNA, and future capability for NAT testing of additional viral markers on the proposed system testing platform e.g. Zika virus testing.
Description of options: Option to extend Contract for 12 months.
Procedure Award criteria
Quality criterion (name): Compliance with User Requirement Specification
Quality criterion (weighting): 14
Cost criterion: Cost
Cost weighting: 6
Award of contract
Date of contract conclusion: 2017-11-13 ๐
Source: OJS 2017/S 222-461282 (2017-11-16)